Safety Evaluation of Bilateral Same-Day Intravitreal Injection of Faricimab
Our study showed that bilateral same-day intravitreal injection of faricimab appeared to be well tolerated in this limited cohort and is the preferred approach in our practice. Larger studies with longer follow-up will be required in order to support our findings.
Authors
- Michael Karampelas (ORCID: https://orcid.org/0000-0002-1344-241X)
- Irini Chatziralli (ORCID: https://orcid.org/0000-0001-8523-1024)
- D Karagiannis
Institutions
- National and Kapodistrian University of Athens (GR)
Publication Details
- Journal
- Ophthalmology and Therapy
- Published
- 2025-06-22
- DOI
- https://doi.org/10.1007/s40123-025-01184-1
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 1.71